investors.revance.comRevance Therapeutics, Inc. - Investor Relations
investors.revance.com Profile
Investors.revance.com is a subdomain of revance.com, which was created on 2000-07-05,making it 24 years ago.
Discover investors.revance.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investors.revance.com Information
| HomePage size: 87.784 KB |
| Page Load Time: 0.501969 Seconds |
| Website IP Address: 162.159.130.11 |
investors.revance.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
| Investor Relations | Jacobs - Investor Relations |
investors.revance.com PopUrls
| Revance Therapeutics, Inc. - Investor Relations https://investors.revance.com/overview/default.aspx |
| Revance Therapeutics, Inc. - investors - Stock Information https://investors.revance.com/investors/stock-info/default.aspx |
| Revance Therapeutics, Inc. - Revance Reports Third Quarter 2023 ... https://investors.revance.com/investors/Press-Releases/news-details/2023/Revance-Reports-Third-Quarter-2023-Financial-Results-Provides-Corporate-Updat |
| Revance Therapeutics, Inc. - Revance Reports Fourth Quarter and Full ... https://investors.revance.com/investors/Press-Releases/news-details/2023/Revance-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-Provides- |
| Revance Therapeutics, Inc. - U.S. FDA Approves First Therapeutic ... https://investors.revance.com/investors/Press-Releases/news-details/2023/U.S.-FDA-Approves-First-Therapeutic-Indication-for-Revances-DAXXIFY-Daxibotul |
| Annual Reports and Proxies - investors.revance.com https://investors.revance.com/investors/financials/annual-reports/default.aspx |
| Revance Therapeutics, Inc. - Revance Reports Third Quarter 2022 ... https://investors.revance.com/investors/Press-Releases/news-details/2022/Revance-Reports-Third-Quarter-2022-Financial-Results-Provides-Corporate-Updat |
| Revance Therapeutics, Inc. - investors - Press Releases https://investors.revance.com/investors/Press-Releases/default.aspx |
| Revance Therapeutics, Inc. - Revance Announces U.S. FDA Acceptance of ... https://investors.revance.com/investors/Press-Releases/news-details/2023/Revance-Announces-U.S.-FDA-Acceptance-of-Supplemental-Biologics-License-Appli |
| Revance Therapeutics, Inc. - Revance to Release Third Quarter 2023 ... https://investors.revance.com/investors/Press-Releases/news-details/2023/Revance-to-Release-Third-Quarter-2023-Financial-Results-on-Wednesday-November |
investors.revance.com Httpheader
| Date: Tue, 14 May 2024 14:31:30 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| CF-Ray: 883b979d9cabfac6-SJC |
| CF-Cache-Status: REVALIDATED |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-Frame-Options: SAMEORIGIN |
| X-XSS-Protection: 1; mode=block |
| Server: cloudflare |
investors.revance.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
| content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.bootstrapcdn.com unpkg.com *.addtoany.com *.jsdelivr.net *.unpkg.com *.datatables.net *.cloudfront.net *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com" http-equiv="Content-Security-Policy"/ |
| content="UaULheNrbu14D76gPMKhvP4JzP567mSvvzUrqjlp3oU" name="google-site-verification"/ |
investors.revance.com Html To Plain Text
overview Company products and pipeline investors Investor Relations Press Releases Events + Presentations Events Presentations and Corporate Material Financials & Fillings SEC Filings Annual Reports and Proxies Quarterly Results Corporate Governance Management Board of Directors Committee Composition Contact the Board Stock Information Historical Stock Quote Investment Calculator Analyst Coverage Investor FAQs Contact Us careers in the news contact usCOMPANY PRODUCTS AND PIPELINE INVESTORS INVESTOR RELATIONS PRESS RELEASES EVENTS + PRESENTATIONS FINANCIALS & FILINGS CORPORATE GOVERNANCE STOCK INFORMATION ANALYST COVERAGE INVESTOR FAQS CONTACT US CAREERS IN THE NEWS CONTACT US User Menu LOGIN Investor Relations IR MENU overview Company products and pipeline investors Investor Relations Press Releases Events + Presentations Events Presentations and Corporate Material Financials & fillings SEC Filings Annual Reports and Proxies Quarterly Results Corporate Governance Committee Composition Management Board of Directors Contact the Board Stock Information Historical Stock Quote Investment Calculator Analyst Coverage Investor FAQs Contact Us careers in the news contact us login INVESTORS Investor Relations Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences. Investor Relations FRONTQuick Links Events and Presentations UPCOMING AND ARCHIVED Press Releases CURRENT AND ARCHIVED Presentations and Corporate Materials CURRENT AND HISTORICAL Financials and Filings SEC FILINGS Stock Information QUOTE, HISTORICAL, CALCULATOR Analyst Coverage SELL SIDE Corporate Governance MANAGEMENT, BOARD, COMMITTEES Frequently Asked Questions GENERAL INFORMATION Investor Inquiries INVESTOR RELATIONS CONTACTS overview Company products and pipeline investors Investor Relations Press Releases Events + Presentations Events Presentations and Corporate Material Financials & Fillings SEC Filings Annual Reports and Proxies Quarterly Results Corporate Governance Management Board of Directors Committee Composition Contact the Board Stock Information Historical Stock Quote Investment Calculator Analyst Coverage Investor FAQs Contact Us careers in the news contact us Search queryToolkit Print Page Print Materials Email Alerts Download Library RSS Newsfeed ShareFooter Menu COMPANY ABOUTPRODUCTS AND PIPELINE LEADERSHIP TEAM BOARD PARTNERSHIPS CONTACT US INVESTORS INVESTOR RELATIONS FINANCIALS AND FILINGS CORPORATE GOVERNANCE ANALYST COVERAGE INVESTOR FAQS PRESS RELEASES CAREERS OPPORTUNITIES CULTURE BENEFITS MEDIA NEWSSocial Links Facebook Instagram Twitter LinkedIn For customer service, product information, new accounts or adverse events call: 877-3REV-NOW For all other inquires call: +1 (510) 742-3400 1222 Demonbreun St 20th Floor Nashville, TN 37203 © COPYRIGHT 2023 ALL RIGHTS RESERVEDFooter Links SOCIAL MEDIA COMMUNITY GUIDELINES PRIVACY POLICY TERMS OF...
investors.revance.com Whois
Domain Name: REVANCE.COM Registry Domain ID: 30896631_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-07-07T14:58:59Z Creation Date: 2000-07-05T18:33:11Z Registry Expiry Date: 2026-07-05T18:33:11Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1-03.AZURE-DNS.COM Name Server: NS2-03.AZURE-DNS.NET Name Server: NS3-03.AZURE-DNS.ORG Name Server: NS4-03.AZURE-DNS.INFO DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:32:05Z <<<